Iambic Therapeutics Files for Nasdaq IPO at $16 a Share
The company is offering 9,375,000 shares under ticker IAM, with gross proceeds expected to be $150 million. Underwriters have a 30-day option.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.